| Utestående aktier | 2,174,841 shares |
| Insideraktier | 1 489 428 shares |
| Insynsägande | 68,48 % |
| Totalt antal insynspersoner | 33 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
5904 out of 11218Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Jaguar Health, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Ari Azhir | 39 286 | ||
| James J Bochnowski Director - [D] | 78 876 | 1 856 | |
|
Bvcf Iii, L.p.
10% Owner -
|
1 522 881 | 36 844 | |
|
Bvcf Iii-a, L.p.
10% Owner -
|
1 522 881 | 36 844 | |
|
BVCF Management, Ltd.
10% Owner -
|
1 522 881 | 36 844 | |
| Philippe Brianceau | 20 000 | ||
| Bryan Ezralow 1994 Trust dated December 22, 1994 - | 2 916 667 | 62 589 | |
|
Capital Ltd Burford
10% Owner -
|
0 | 0 | |
| Lisa A Conte CEO and President, Director - [D] [O] | 666 | 666 | |
| Pravin R Chaturvedi Chief Scientific Officer - [O] | 4 957 | 198 | |
| Greg J Divis Director - [D] | 12 133 | 227 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Bryan Ezralow
10% Owner -
|
2 916 667 | 62 589 | |
| Jonathan M Glaser - | 720 405 | 15 459 | |
| Michael Hauser | 73 000 | ||
| Johnson Jeffery C. | 121 573 | ||
| Anula Jayasuriya Director - [D] | 70 286 | 1 654 | |
| John A Kallassy | 13 365 | ||
| Kamphuis Folkert W. | 53 164 | ||
| King Steven R. See Remarks - [O] | 145 | 145 | |
|
Kunlun Pharmaceuticals, Ltd.
10% Owner -
|
1 522 881 | 36 844 | |
|
Lincoln Alternative Strategies LLC
10% Owner -
|
1 200 000 | 1 200 000 | |
| Lizak Carol R. Chief Financial Officer - [O] | 4 297 | 172 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| John Micek Director - [D] | 80 701 | 1 899 | |
| Murray David MacNaughtan | 121 573 | ||
|
Napo Pharmaceuticals Inc
10% Owner -
|
5 333 332 | 129 032 | |
|
Nantucket Investments Ltd
10% Owner -
|
0 | 0 | |
| Jiahao Qiu | 12 965 | ||
| Sagard Capital Partners, L.P. | 5 524 926 | ||
| Siegel Jonathan B. Director - [D] | 69 874 | 1 644 | |
| Waltzman Roger J. | 2 866 | ||
| Wolin Jonathan S. See Remarks - [O] | 4 955 | 198 | |
| Karen Steil Wright | 303 932 | ||
|
Zhi Yang
Director, 10% Owner -
[D]
|
1 522 881 | 36 844 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i JAGX / Jaguar Health, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i JAGX / Jaguar Health, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-29 | 3 | Lincoln Alternative Strategies LLC | JAGX | Common Stock, par value $0.0001 per share | D | 600 000 | ||||||||
| 2025-05-20 | 2025-05-17 | 4 | CONTE LISA A | JAGX | Common Stock | D | 2 | 666 | ||||||
| 2025-05-20 | 2025-05-17 | 4 | King Steven R. | JAGX | Common Stock | D | 1 | 145 | ||||||
| 2024-10-10 | 2024-10-08 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 4 280 | 4 297 | ||||||
| 2024-10-10 | 2024-10-08 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 4 922 | 4 955 | ||||||
| 2024-10-10 | 2024-10-08 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 4 922 | 4 957 | ||||||
| 2024-10-10 | 2024-10-08 | 4 | CONTE LISA A | JAGX | Common Stock | D | 16 503 | 16 624 | ||||||
| 2024-10-10 | 2024-10-08 | 4 | King Steven R. | JAGX | Common Stock | D | 4 922 | 4 951 | ||||||
| 2024-05-21 | 2024-05-17 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 871 | 2 012 | ||||||
| 2024-05-21 | 2024-05-17 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 871 | 2 141 | ||||||
| 2024-05-21 | 2024-05-17 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 431 | 1 042 | ||||||
| 2024-05-21 | 2024-05-17 | 4 | King Steven R. | JAGX | Common Stock | D | 612 | 1 756 | ||||||
| 2024-05-21 | 2024-05-17 | 4 | CONTE LISA A | JAGX | Common Stock | D | 2 695 | 7 295 | ||||||
| 2024-04-17 | 2024-04-05 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 134 | 1 270 | ||||||
| 2024-04-17 | 2024-04-05 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 60 | 611 | ||||||
| 2024-04-17 | 2024-04-05 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 89 | 1 141 | ||||||
| 2024-04-17 | 2024-04-05 | 4 | King Steven R. | JAGX | Common Stock | D | 178 | 1 144 | ||||||
| 2024-04-17 | 2024-04-05 | 4 | CONTE LISA A | JAGX | Common Stock | D | 600 | 4 600 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | Siegel Jonathan B. | JAGX | Common Stock | D | 68 568 | 69 874 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | MICEK JOHN | JAGX | Common Stock | D | 68 568 | 80 701 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | BOCHNOWSKI JAMES J | JAGX | Common Stock | D | 76 613 | 78 876 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | CONTE LISA A | JAGX | Common Stock | D | 383 605 | 387 605 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | King Steven R. | JAGX | Common Stock | D | 159 168 | 160 133 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 142 088 | 142 745 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 196 628 | 197 680 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | Jayasuriya Anula | JAGX | Common Stock | D | 68 568 | 70 286 | ||||||
| 2023-08-14 | 2023-07-01 | 4 | Jayasuriya Anula | JAGX | Common Stock | D | 1 718 | 1 718 | ||||||
| 2023-08-14 | 2023-08-14 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 204 192 | 205 328 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 870 | 1 136 | ||||||
| 2023-05-19 | 2023-04-05 | 4/A | Chaturvedi Pravin R | JAGX | Common Stock | D | 133 | 266 | ||||||
| 2023-05-19 | 2022-04-05 | 4/A | Chaturvedi Pravin R | JAGX | Common Stock | D | 10 000 | 10 000 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | MICEK JOHN | JAGX | Common Stock | D | 1 145 | 1 306 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | Siegel Jonathan B. | JAGX | Common Stock | D | 1 145 | 1 306 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | BOCHNOWSKI JAMES J | JAGX | Common Stock | D | 1 280 | 2 263 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | King Steven R. | JAGX | Common Stock | D | 611 | 965 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 431 | 657 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 871 | 1 052 | ||||||
| 2023-05-19 | 2023-05-17 | 4 | CONTE LISA A | JAGX | Common Stock | D | 2 694 | 4 000 | ||||||
| 2023-04-20 | 2023-04-05 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 60 | 226 | ||||||
| 2023-04-20 | 2023-04-05 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 44 | 88 | ||||||
| 2023-04-20 | 2023-04-05 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 88 | 181 | ||||||
| 2023-04-20 | 2023-04-05 | 4 | King Steven R. | JAGX | Common Stock | D | 177 | 354 | ||||||
| 2023-04-20 | 2023-04-05 | 4 | CONTE LISA A | JAGX | Common Stock | D | 600 | 1 306 | ||||||
| 2023-01-03 | 2022-12-31 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 0,0300 | 317 | 0 | 6 983 | ||||
| 2022-05-18 | 2022-05-18 | 4 | BOCHNOWSKI JAMES J | JAGX | Restricted stock units | D | −13 133 | 0 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | BOCHNOWSKI JAMES J | JAGX | Common Stock | D | 13 133 | 73 765 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | Siegel Jonathan B. | JAGX | Restricted stock units | D | −12 133 | 0 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | Siegel Jonathan B. | JAGX | Common Stock | D | 12 133 | 12 133 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | DIVIS GREG J | JAGX | Restricted stock units | D | −12 133 | 0 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | DIVIS GREG J | JAGX | Common Stock | D | 12 133 | 12 133 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | MICEK JOHN | JAGX | Restricted stock units | D | −12 133 | 0 | ||||||
| 2022-05-18 | 2022-05-18 | 4 | MICEK JOHN | JAGX | Common Stock | D | 12 133 | 12 133 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Chaturvedi Pravin R | JAGX | Restricted stock units | D | 3 333 | 6 666 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Chaturvedi Pravin R | JAGX | Common Stock | D | 3 333 | 3 333 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Lizak Carol R. | JAGX | Restricted stock units | D | 4 513 | 9 028 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Lizak Carol R. | JAGX | Common Stock | D | 4 513 | 12 481 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Wolin Jonathan S. | JAGX | Restricted stock units | D | 6 666 | 13 333 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | Wolin Jonathan S. | JAGX | Common Stock | D | 6 666 | 6 666 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | CONTE LISA A | JAGX | Restricted stock units | D | 45 000 | 90 000 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | CONTE LISA A | JAGX | Common Stock | D | 45 000 | 53 003 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | King Steven R. | JAGX | Restricted stock units | D | 13 333 | 26 666 | ||||||
| 2022-04-06 | 2022-04-05 | 4 | King Steven R. | JAGX | Common Stock | D | 13 333 | 13 333 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | DIVIS GREG J | JAGX | Restricted stock units | D | 85 900 | 85 900 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | Siegel Jonathan B. | JAGX | Restricted stock units | D | 85 900 | 85 900 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | MICEK JOHN | JAGX | Restricted stock units | D | 85 900 | 85 900 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | BOCHNOWSKI JAMES J | JAGX | Restricted stock units | D | 96 015 | 96 015 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | Chaturvedi Pravin R | JAGX | Restricted stock units | D | 195 934 | 195 934 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | Lizak Carol R. | JAGX | Restricted stock units | D | 97 025 | 97 025 | ||||||
| 2022-03-30 | 2021-09-13 | 4 | Lizak Carol R. | JAGX | Common Stock | I | 2,5100 | 7 968 | 20 | 7 968 | ||||
| 2022-03-30 | 2022-03-28 | 4 | Wolin Jonathan S. | JAGX | Restricted stock units | D | 196 018 | 196 018 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | King Steven R. | JAGX | Restricted stock units | D | 137 685 | 137 685 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | CONTE LISA A | JAGX | Restricted stock units | D | 25 000 | 25 000 | ||||||
| 2022-03-30 | 2022-03-28 | 4 | CONTE LISA A | JAGX | Restricted stock units | D | 606 280 | 606 280 | ||||||
| 2022-03-30 | 2021-09-13 | 4 | CONTE LISA A | JAGX | Common Stock | D | 2,5100 | 7 968 | 20 | 8 003 | ||||
| 2021-06-07 | 2021-06-04 | 4 | BOCHNOWSKI JAMES J | JAGX | Common Stock | D | 1,7400 | −152 | −0 | 954 390 | ||||
| 2021-06-07 | 2021-06-03 | 4 | BOCHNOWSKI JAMES J | JAGX | Common Stock | D | 1,7500 | −292 | −1 | 954 542 | ||||
| 2021-05-20 | 2021-05-18 | 4 | Siegel Jonathan B. | JAGX | Restricted stock units | D | 36 400 | 36 400 | ||||||
| 2021-05-20 | 2021-05-18 | 4 | Siegel Jonathan B. | JAGX | Stock option (right to buy) | D | 1,24 | 72 750 | 72 750 | |||||
| 2021-05-20 | 2021-05-18 | 4 | MICEK JOHN | JAGX | Restricted stock units | D | 36 400 | 36 400 | ||||||
| 2021-05-20 | 2021-05-18 | 4 | MICEK JOHN | JAGX | Stock option (right to buy) | D | 1,24 | 72 750 | 72 750 | |||||
| 2021-05-20 | 2021-05-18 | 4 | DIVIS GREG J | JAGX | Restricted stock units | D | 36 400 | 36 400 | ||||||
| 2021-05-20 | 2021-05-18 | 4 | DIVIS GREG J | JAGX | Stock option (right to buy) | D | 1,24 | 72 750 | 72 750 | |||||
| 2021-05-20 | 2021-05-18 | 4 | BOCHNOWSKI JAMES J | JAGX | Restricted stock units | D | 39 400 | 39 400 | ||||||
| 2021-05-20 | 2021-05-18 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock option (right to buy) | D | 1,24 | 78 750 | 78 750 | |||||
| 2021-04-07 | 2021-04-05 | 4 | Lizak Carol R. | JAGX | Restricted stock units | D | 40 625 | 40 625 | ||||||
| 2021-04-07 | 2021-04-05 | 4 | Lizak Carol R. | JAGX | Stock option (right to buy) | D | 1,99 | 81 250 | 81 250 | |||||
| 2021-04-07 | 2021-04-05 | 4 | Wolin Jonathan S. | JAGX | Restricted stock units | D | 60 000 | 60 000 | ||||||
| 2021-04-07 | 2021-04-05 | 4 | Wolin Jonathan S. | JAGX | Stock option (right to buy) | D | 1,99 | 120 000 | 120 000 | |||||
| 2021-04-07 | 2021-04-05 | 4 | King Steven R. | JAGX | Restricted stock units | D | 120 000 | 120 000 | ||||||
| 2021-04-07 | 2021-04-05 | 4 | King Steven R. | JAGX | Stock option (right to buy) | D | 1,99 | 240 000 | 240 000 | |||||
| 2021-04-07 | 2021-04-05 | 4 | CONTE LISA A | JAGX | Restricted stock units | D | 405 000 | 405 000 | ||||||
| 2021-04-07 | 2021-04-05 | 4 | CONTE LISA A | JAGX | Stock option (right to buy) | D | 1,99 | 810 000 | 810 000 | |||||
| 2020-03-25 | 2020-03-20 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock Option (right to buy) | D | 0,45 | 45 486 | 45 486 | |||||
| 2020-03-24 | 2020-03-20 | 4 | Lizak Carol R. | JAGX | Stock Option (right to buy) | D | 0,45 | 50 000 | 50 000 | |||||
| 2020-03-24 | 2020-03-20 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 0,45 | 79 431 | 79 431 | |||||
| 2020-03-24 | 2020-03-20 | 4 | MICEK JOHN | JAGX | Stock Option (right to buy) | D | 0,45 | 26 533 | 26 533 | |||||
| 2020-03-24 | 2020-03-20 | 4 | Siegel Jonathan B. | JAGX | Stock Option (right to buy) | D | 0,45 | 45 486 | 45 486 | |||||
| 2020-03-24 | 2020-03-20 | 4 | Wolin Jonathan S. | JAGX | Stock Option (right to buy) | D | 0,45 | 59 753 | 59 753 | |||||
| 2020-03-24 | 2020-03-20 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 0,45 | 238 293 | 238 293 | |||||
| 2020-03-24 | 2020-03-20 | 4 | DIVIS GREG J | JAGX | Stock option (right to buy) | D | 0,45 | 26 533 | 26 533 | |||||
| 2019-07-26 | 2019-07-24 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 1,73 | 347 351 | 347 351 | |||||
| 2019-07-26 | 2019-07-24 | 4 | DIVIS GREG J | JAGX | Stock Option (right to buy) | D | 1,73 | 121 573 | 121 573 | |||||
| 2019-07-26 | 2019-07-24 | 4 | JOHNSON JEFFERY C. | JAGX | Stock Option (right to buy) | D | 1,73 | 121 573 | 121 573 | |||||
| 2019-07-26 | 2019-07-24 | 4 | MacNaughtan Murray David | JAGX | Stock Option (right to buy) | D | 1,73 | 121 573 | 121 573 | |||||
| 2019-07-26 | 2019-07-24 | 4 | MICEK JOHN | JAGX | Stock Option (right to buy) | D | 1,73 | 121 573 | 121 573 | |||||
| 2019-07-26 | 2019-07-24 | 4 | Wright Karen Steil | JAGX | Stock Option (right to buy) | D | 1,73 | 303 932 | 303 932 | |||||
| 2019-07-25 | 2019-07-24 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 1,73 | 1 042 052 | 1 042 052 | |||||
| 2019-07-25 | 2019-06-07 | 4 | CONTE LISA A | JAGX | Bridge Warrant to Purchase Common Stock | D | 2,00 | 37 500 | 37 500 | |||||
| 2019-07-25 | 2019-07-24 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock Option (right to buy) | D | 1,73 | 208 410 | 208 410 | |||||
| 2019-07-25 | 2019-07-23 | 4 | BOCHNOWSKI JAMES J | JAGX | Series 1 Warrant to Purchase Common Stock | I | 2,00 | 180 582 | 180 582 | |||||
| 2019-07-25 | 2019-07-23 | 4 | BOCHNOWSKI JAMES J | JAGX | Series 2 Warrant to Purchase Common Stock | I | 2,00 | 180 582 | 180 582 | |||||
| 2019-07-25 | 2019-07-23 | 4 | BOCHNOWSKI JAMES J | JAGX | Common Stock | I | 2,0000 | 180 582 | 361 | 181 618 | ||||
| 2019-07-25 | 2019-05-24 | 4 | BOCHNOWSKI JAMES J | JAGX | Bridge Warrant to Purchase Common Stock | I | 2,00 | 218 750 | 218 750 | |||||
| 2019-07-25 | 2019-07-24 | 4 | Siegel Jonathan B. | JAGX | Stock Option (right to buy) | D | 1,73 | 208 410 | 208 410 | |||||
| 2019-07-25 | 2019-07-23 | 4 | Siegel Jonathan B. | JAGX | Series 1 Warrant to Purchase Common Stock | I | 2,00 | 12 705 | 12 705 | |||||
| 2019-07-25 | 2019-07-23 | 4 | Siegel Jonathan B. | JAGX | Series 2 Warrant to Purchase Common Stock | I | 2,00 | 12 705 | 12 705 | |||||
| 2019-07-25 | 2019-07-23 | 4 | Siegel Jonathan B. | JAGX | Common Stock | I | 2,0000 | 12 705 | 25 | 13 276 | ||||
| 2019-07-25 | 2019-05-31 | 4 | Siegel Jonathan B. | JAGX | Bridge Warrant to Purchase Common Stock | I | 2,00 | 34 375 | 34 375 | |||||
| 2019-03-15 | 2019-03-14 | 4 | Sagard Capital Partners, L.P. | JAGX | Series A Convertible Participating Preferred Stock | I | 0,28 | 5 524 926 | 5 524 926 | |||||
| 2019-03-15 | 2019-03-14 | 4 | Sagard Capital Partners, L.P. | JAGX | Series A Convertible Participating Preferred Stock | I | 2,78 | −5 524 926 | 0 | |||||
| 2018-10-24 | 2018-09-25 | 4 | Nantucket Investments Ltd | JAGX | Non-Voting Common Stock | D | 1,8300 | 270 270 | 495 | 38 180 451 | ||||
| 2018-10-24 | 2018-09-25 | 4 | Nantucket Investments Ltd | JAGX | Common Stock | D | 1,8300 | −325 615 | −596 | 0 | ||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 | JAGX | Common Stock | I | 2 916 667 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 | JAGX | Common Stock | I | 2 916 667 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC | JAGX | Common Stock | I | 2 083 334 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 | JAGX | Common Stock | I | 2 916 667 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC | JAGX | Common Stock | I | 2 083 334 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By Bryan Ezralow 1994 Trust u/t/d December 22, 1994 | JAGX | Common Stock | I | 2 916 667 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC | JAGX | Common Stock | I | 2 083 334 | ||||||||
| 2018-10-12 | 3 | Bryan Ezralow 1994 Trust dated December 22, 1994 By EZ MM&B Holdings, LLC | JAGX | Common Stock | I | 2 083 334 | ||||||||
| 2018-10-05 | 2018-10-04 | 4 | Siegel Jonathan B. | JAGX | Common Stock | I | 0,6000 | 25 000 | 15 | 40 000 | ||||
| 2018-10-04 | 2018-07-17 | 4/A | Siegel Jonathan B. | JAGX | Common Stock | I | 1,1900 | 268 | 0 | 15 000 | ||||
| 2018-09-25 | 2018-09-25 | 4 | GLASER JONATHAN M By Pacific Capital Management, LLC | JAGX | Common Stock | I | −60 000 | 720 405 | ||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By JLA Family Limited Partnership | JAGX | Common Stock | I | 938 953 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan | JAGX | Common Stock | I | 1 018 001 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By JLA Family Limited Partnership | JAGX | Common Stock | I | 938 953 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By Pacific Capital Management, LLC | JAGX | Common Stock | I | 1 692 858 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan | JAGX | Common Stock | I | 1 018 001 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By Pacific Capital Management, LLC | JAGX | Common Stock | I | 1 692 858 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By JMG Capital Management LLC 401(k) Profit Sharing Plan | JAGX | Common Stock | I | 1 018 001 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By JLA Family Limited Partnership | JAGX | Common Stock | I | 938 953 | ||||||||
| 2018-08-03 | 3 | GLASER JONATHAN M By Pacific Capital Management, LLC | JAGX | Common Stock | I | 1 692 858 | ||||||||
| 2018-07-20 | 2018-07-18 | 4 | Siegel Jonathan B. | JAGX | Common Stock | I | 1,0952 | 5 000 | 5 | 14 732 | ||||
| 2018-07-18 | 2018-07-18 | 4 | CONTE LISA A | JAGX | Common Stock | D | 1,1124 | 1 500 | 2 | 7 500 | ||||
| 2018-07-18 | 2018-07-17 | 4 | Siegel Jonathan B. | JAGX | Common Stock | I | 1,1900 | 2 232 | 3 | 9 732 | ||||
| 2018-07-18 | 2018-07-16 | 4 | Siegel Jonathan B. | JAGX | Common Stock | I | 1,3586 | 7 500 | 10 | 9 732 | ||||
| 2018-07-13 | 2018-07-11 | 4 | MacNaughtan Murray David | JAGX | Stock Option (right to buy) | D | 1,36 | 104 860 | 104 860 | |||||
| 2018-07-13 | 2018-07-11 | 4 | DIVIS GREG J | JAGX | Stock Option (right to buy) | D | 1,36 | 104 860 | 104 860 | |||||
| 2018-06-06 | 2018-03-12 | 4 | Qiu Jiahao | JAGX | Stock Option (right to buy) | D | 8,40 | 12 965 | 12 965 | |||||
| 2018-06-06 | 2018-03-12 | 4 | Kamphuis Folkert W. | JAGX | Stock Option (right to buy) | D | 8,40 | 53 164 | 53 164 | |||||
| 2018-06-06 | 2018-03-12 | 4 | Yang Zhi | JAGX | Stock Option (right to buy) | D | 8,40 | 12 965 | 12 965 | |||||
| 2018-06-06 | 2018-03-12 | 4 | Azhir Ari | JAGX | Stock Option (right to buy) | D | 8,40 | 39 286 | 39 286 | |||||
| 2018-06-06 | 2018-06-01 | 4 | Wright Karen Steil | JAGX | Stock Option (right to buy) | D | 2,73 | 85 854 | 85 854 | |||||
| 2018-06-06 | 2018-06-01 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 2,73 | 149 311 | 149 311 | |||||
| 2018-06-06 | 2018-06-01 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock Option (right to buy) | D | 2,39 | 251 665 | 251 665 | |||||
| 2018-06-06 | 2018-03-12 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock Option (right to buy) | D | 8,40 | 71 709 | 71 709 | |||||
| 2018-06-06 | 2018-06-01 | 4 | MICEK JOHN | JAGX | Stock Option (right to buy) | D | 2,39 | 146 804 | 146 804 | |||||
| 2018-06-06 | 2018-03-12 | 4 | MICEK JOHN | JAGX | Stock Option (right to buy) | D | 8,40 | 38 643 | 38 643 | |||||
| 2018-06-06 | 2018-06-01 | 4 | Siegel Jonathan B. | JAGX | Stock Option (right to buy) | D | 2,73 | 104 860 | 104 860 | |||||
| 2018-06-06 | 2018-06-01 | 4 | JOHNSON JEFFERY C. | JAGX | Stock Option (right to buy) | D | 2,73 | 104 860 | 104 860 | |||||
| 2018-06-06 | 2018-06-01 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 2,73 | 447 935 | 447 935 | |||||
| 2018-03-14 | 2018-03-12 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 0,56 | 3 247 242 | 3 247 242 | |||||
| 2018-03-14 | 2018-03-12 | 4 | Wright Karen Steil | JAGX | Stock Option (right to buy) | D | 0,56 | 998 857 | 998 857 | |||||
| 2018-03-14 | 2018-03-12 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 0,56 | 1 327 881 | 1 327 881 | |||||
| 2017-12-29 | 2017-12-21 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 0,12 | 285 807 | 285 807 | |||||
| 2017-12-29 | 2017-12-21 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 0,12 | 95 269 | 95 269 | |||||
| 2017-12-29 | 2017-12-21 | 4 | Wright Karen Steil | JAGX | Stock Option (right to buy) | D | 0,12 | 54 295 | 54 295 | |||||
| 2017-08-09 | 3 | Nantucket Investments Ltd | JAGX | Common Stock, par value $0.0001 per share ("Common Stock") | D | 9 768 490 | ||||||||
| 2017-08-09 | 3 | Nantucket Investments Ltd | JAGX | Common Stock, par value $0.0001 per share ("Common Stock") | D | 9 768 490 | ||||||||
| 2017-08-09 | 3 | Nantucket Investments Ltd | JAGX | Common Stock, par value $0.0001 per share ("Common Stock") | D | 9 768 490 | ||||||||
| 2017-08-02 | 2017-06-28 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 0,5000 | 100 000 | 50 | 797 935 | ||||
| 2016-12-21 | 2016-12-19 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 0,74 | 16 998 | 16 998 | |||||
| 2016-12-21 | 2016-12-19 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock Option (right to buy) | D | 0,74 | 16 378 | 16 378 | |||||
| 2016-12-21 | 2016-12-19 | 4 | MICEK JOHN | JAGX | Stock Option (right to buy) | D | 0,74 | 10 884 | 10 884 | |||||
| 2016-12-21 | 2016-12-19 | 4 | Wright Karen Steil | JAGX | Stock Option (right to buy) | D | 0,74 | 2 866 | 2 866 | |||||
| 2016-12-21 | 2016-12-19 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 0,74 | 4 496 | 4 496 | |||||
| 2016-12-21 | 2016-12-19 | 4 | Kamphuis Folkert W. | JAGX | Stock Option (right to buy) | D | 0,74 | 13 771 | 13 771 | |||||
| 2016-12-21 | 2016-12-19 | 4 | Waltzman Roger J. | JAGX | Stock Option (right to buy) | D | 0,74 | 2 866 | 2 866 | |||||
| 2016-11-14 | 2016-08-12 | 4 | Kamphuis Folkert W. | JAGX | Stock Option (right to buy) | D | 1,47 | 50 000 | 50 000 | |||||
| 2016-09-26 | 2016-09-22 | 4 | King Steven R. | JAGX | Stock Option (right to buy) | D | 1,25 | 23 042 | 23 042 | |||||
| 2016-09-26 | 2016-09-22 | 4 | Kamphuis Folkert W. | JAGX | Stock Option (right to buy) | D | 1,25 | 13 000 | 13 000 | |||||
| 2016-09-23 | 2016-09-22 | 4 | CONTE LISA A | JAGX | Stock Option (right to buy) | D | 1,25 | 318 000 | 318 000 | |||||
| 2016-09-23 | 2016-09-22 | 4 | Wright Karen Steil | JAGX | Stock Option (right to buy) | D | 1,25 | 103 698 | 103 698 | |||||
| 2016-09-23 | 2016-09-22 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock Option (right to buy) | D | 1,25 | 75 000 | 75 000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Waltzman Roger J. | JAGX | Stock Option (right to buy) | D | 1,47 | 127 500 | 127 500 | |||||
| 2016-06-16 | 2016-06-14 | 4 | CONTE LISA A | JAGX | Stock option (right to buy) | D | 1,58 | 69 970 | 69 970 | |||||
| 2016-06-16 | 2016-06-14 | 4 | CONTE LISA A | JAGX | Stock option (right to buy) | D | 4,84 | 113 212 | 113 212 | |||||
| 2016-06-16 | 2016-06-14 | 4 | CONTE LISA A | JAGX | Stock option (right to buy) | D | 5,09 | 85 616 | 85 616 | |||||
| 2016-06-16 | 2016-06-14 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock option (right to buy) | D | 1,58 | 11 293 | 11 293 | |||||
| 2016-06-16 | 2016-06-14 | 4 | Wright Karen Steil | JAGX | Stock option (right to buy) | D | 1,58 | 3 802 | 3 802 | |||||
| 2016-06-16 | 2016-06-14 | 4 | Qiu Jiahao | JAGX | Stock option (right to buy) | D | 1,58 | 1 901 | 1 901 | |||||
| 2016-06-16 | 2016-06-14 | 4 | King Steven R. | JAGX | Stock option (right to buy) | D | 1,58 | 28 263 | 28 263 | |||||
| 2016-06-16 | 2016-06-14 | 4 | King Steven R. | JAGX | Stock option (right to buy) | D | 5,09 | 49 942 | 49 942 | |||||
| 2016-06-16 | 2016-06-14 | 4 | Yang Zhi | JAGX | Stock option (right to buy) | D | 1,58 | 1 901 | 1 901 | |||||
| 2016-06-16 | 2016-06-14 | 4 | Kamphuis Folkert W. | JAGX | Stock option (right to buy) | D | 1,58 | 9 504 | 9 504 | |||||
| 2016-04-05 | 2016-04-01 | 4 | Brianceau Philippe | JAGX | Stock Option (right to buy) | D | 1,58 | 20 000 | 20 000 | |||||
| 2016-02-09 | 2016-02-08 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 2,5000 | 160 000 | 400 | 487 576 | ||||
| 2015-06-04 | 2015-06-02 | 4 | BOCHNOWSKI JAMES J | JAGX | Stock option (right to buy) | D | 6,70 | 20 000 | 20 000 | |||||
| 2015-06-04 | 2015-06-02 | 4 | Qiu Jiahao | JAGX | Stock option (right to buy) | D | 6,70 | 10 000 | 10 000 | |||||
| 2015-06-04 | 2015-06-02 | 4 | Yang Zhi | JAGX | Stock option (right to buy) | D | 6,70 | 10 000 | 10 000 | |||||
| 2015-06-04 | 2015-06-02 | 4 | Kamphuis Folkert W. | JAGX | Stock option (right to buy) | D | 6,70 | 50 000 | 50 000 | |||||
| 2015-05-18 | 2015-05-18 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Convertible Promissory Note | I | 5,60 | 0 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Series A Preferred Stock | I | −224 499 | 0 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Convertible Promissory Note | I | 5,60 | 0 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 5,6000 | 44 642 | 250 | 327 576 | ||||
| 2015-05-18 | 2015-05-18 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 5,6000 | 35 714 | 200 | 282 934 | ||||
| 2015-05-18 | 2015-05-18 | 4 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 148 332 | 247 220 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | Kallassy John A | JAGX | Stock Option (right to buy) | D | 7,00 | 13 365 | 13 365 | |||||
| 2015-05-18 | 2015-05-18 | 4 | Yang Zhi By Kunlun Pharmaceuticals, Ltd. | JAGX | Series A Preferred Stock | I | −2 224 991 | 0 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | Yang Zhi | JAGX | Common Stock | I | 1 483 326 | 1 522 881 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | BVCF Management, Ltd. By Kunlun Pharmaceuticals, Ltd. | JAGX | Series A Preferred Stock | I | −2 224 991 | 0 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | BVCF Management, Ltd. | JAGX | Common Stock | I | 1 483 326 | 1 522 881 | ||||||
| 2015-05-18 | 2015-05-18 | 4 | Hauser Michael | JAGX | Stock Option (right to buy) | D | 7,00 | 73 000 | 73 000 | |||||
| 2015-05-13 | 3 | BVCF III-A, L.P. By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | BVCF III-A, L.P. By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | BVCF III-A, L.P. By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | BVCF III-A, L.P. By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | BVCF III-A, L.P. By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | NAPO PHARMACEUTICALS INC | JAGX | Common Stock | D | 5 333 332 | ||||||||
| 2015-05-13 | 3 | NAPO PHARMACEUTICALS INC | JAGX | Common Stock | D | 5 333 332 | ||||||||
| 2015-05-13 | 3 | Yang Zhi By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | Yang Zhi By Sichuan Biopharma | JAGX | Common Stock | I | 79 110 | ||||||||
| 2015-05-13 | 3 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 197 776 | ||||||||
| 2015-05-13 | 3 | BOCHNOWSKI JAMES J By Bochnowski Family Trust | JAGX | Common Stock | I | 197 776 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
